share_log

上海医药(601607.SH):拟出资10亿元参设并购基金

SH PHARMA (601607.SH): plans to invest 1 billion yuan to establish a merger and acquisition Fund.

Gelonghui Finance ·  Jan 27 08:25

On January 27, Gelonghui reported that SH PHARMA (601607.SH) announced its intention to participate as one of the limited partners in the establishment of a merger and acquisition Fund, with total fundraising expected to reach 5.01 billion yuan, of which SH PHARMA will contribute 1 billion yuan from its own funds. The targeted Fund will focus on the overall development strategy of the Shanghai Biomedical industry, linking Global resources and serving Shanghai's functional positioning. It aims to promote Shanghai's capability to attract and integrate both Global and domestic Biomedical industry innovation resources, collaborate with key areas of Shanghai's Biomedical industry, focus on sub-sectors that are crucial for Shanghai's Biomedical development, and push Shanghai to become a high ground for Biomedical research, economic growth, and industrialization. This will enhance the role of the Industry Chain in leading, driving, and connecting, while also aiming to provide good investment returns for all partners by investing in accordance with applicable laws and the terms of this agreement.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 325

Recommended

Write a comment

Statement

This page is machine-translated. Moomoo tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.